ArticleCancers2019

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.

Francesca Collina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.